Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Mangoceuticals, Inc.(MGRX US)

Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Mangoceuticals, Inc.(MGRX US)

Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
MGRX US​
Ask AI
MGRX US​
Ask AI

Financials

Income Statement

Balance SheetCash Flow
Millions USD (ex. Per Share)
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue0.70.60.50.4
-Cost of Revenue0.30.20.20.2
Gross Profit0.40.40.30.2
-Operating Expenses9.78.419.417.6
+Selling, General & Admin5.47.916.72.2
+General And Administrative Expenses3.36.415.91.6
+Selling And Marketing Expenses2.11.50.80.6
+Research and Development----
+Other Operating Expenses4.20.52.715.4
Operating Income-9.2-8.0-19.2-17.4
+Non Operating Income0.0-0.7-1.6-2.2
+Interest Income, Net--0.0-0.1-0.4
+Interest Income----
-Interest Expense-0.00.10.4
+Other Non-Op Income0.0-0.7-1.5-1.8
Pretax Income-9.2-8.7-20.6-19.2
-Income Tax Expense----
Income from Cont Ops-9.2-8.7-20.6-19.2
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI-9.2-8.7-20.6-19.2
-Minority Interests--0.0-0.0
Net Income, GAAP-9.2-8.7-20.6-19.2
-Prfrrd Div & Other----
Net Income Avail To Common-9.2-8.7-20.6-19.2
Weighted Average Shs Out1,074,0001,978,96610,071,60941,650,869
EPS-8.6-4.4-2.1-1.8
Weighted Average Shs Out Dil1,074,0001,978,96610,071,60941,650,869
EPS Diluted-8.6-4.4-2.1-1.8

Financials

Income Statement

Balance SheetCash Flow
Millions USD (ex. Per Share)
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue0.70.60.50.4
-Cost of Revenue0.30.20.20.2
Gross Profit0.40.40.30.2
-Operating Expenses9.78.419.417.6
+Selling, General & Admin5.47.916.72.2
+General And Administrative Expenses3.36.415.91.6
+Selling And Marketing Expenses2.11.50.80.6
+Research and Development----
+Other Operating Expenses4.20.52.715.4
Operating Income-9.2-8.0-19.2-17.4
+Non Operating Income0.0-0.7-1.6-2.2
+Interest Income, Net--0.0-0.1-0.4
+Interest Income----
-Interest Expense-0.00.10.4
+Other Non-Op Income0.0-0.7-1.5-1.8
Pretax Income-9.2-8.7-20.6-19.2
-Income Tax Expense----
Income from Cont Ops-9.2-8.7-20.6-19.2
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI-9.2-8.7-20.6-19.2
-Minority Interests--0.0-0.0
Net Income, GAAP-9.2-8.7-20.6-19.2
-Prfrrd Div & Other----
Net Income Avail To Common-9.2-8.7-20.6-19.2
Weighted Average Shs Out1,074,0001,978,96610,071,60941,650,869
EPS-8.6-4.4-2.1-1.8
Weighted Average Shs Out Dil1,074,0001,978,96610,071,60941,650,869
EPS Diluted-8.6-4.4-2.1-1.8